The messages people under 60 have been getting about the AstraZeneca vaccine this week have been confusing, to say the least. Experts say to consider the risks and benefits. But how do you do this?
Disiplin ilmiah, gaya jurnalistik
Artikel-artikel mengenai COVID-19 vaccine rollout
Menampilkan 21 - 40 dari 87 artikel
With enough vaccine supplies coming online from October, the government has no excuse not to have all arrangements in place for an efficient vaccination program. Here’s what needs to change.
While Pfizer is still the preferred vaccine for under 40s, those who don’t want to wait can now talk to their GP about getting an AstraZeneca shot. But what risks and benefits do you need to weigh up?
The rules around allocation, and the enforcement of those rules, can’t rest with each individual. Responsibility lies with those in charge of delivering vaccines.
In Australia, a preference for a particular brand of COVID vaccine is likely to change, depending on the latest health advice, and media reports.
Our brains cannot easily understand tiny risks so we tend to overestimate them. That’s when we need a little extra help to make the best decisions about our health.
Even if we came up with a definition of what makes the “best” vaccine, we don’t have the luxury of choice, when vaccines are in short supply.
Community pharmacies and pharmacists are important resources in Australia’s vaccine rollout, and right now they’re being under-utilised.
Australia is now rolling out the Pfizer vaccine to people aged under 50, with the 40-49 age group newly eligible. Here’s what you can expect.
History tells us the public will tolerate risk of harm from a vaccine if their fear of the disease exceeds their fear of the vaccine.
Australia’s growing tendency to call in the defence force to deal with crises outside its usual remit is cause for concern. Shouldn’t we be better prepared to respond to disasters?
We want to get everybody vaccinated. Opening up to younger age groups could be one way to speed things up — but it will come with logistical challenges too.
Australia’s COVID vaccine rollout has now reached people of working age. Here’s what you need to know about taking time off for your shot and if you’ll get paid.
From free beers to lottery tickets, many jurisdictions around the world have introduced vaccine incentives. Is it time for Australia to do the same?
In the end, the best protection is mass vaccination and ensuring as many people as possible are fully vaccinated as quickly as possible.
Many over 50s seem to be asking this question. But there are a number of reasons it’s important to go ahead and get the AstraZeneca vaccine now.
Australians over 50 can get their AstraZeneca vaccine from a GP clinic from today. Here’s what you need to know when you book yourself in.
Many people are unsure if their condition qualifies as an underlying medical condition. They may not realise they’re already eligible for the COVID vaccine.
The AstraZeneca COVID vaccine is now available to Australians over 50. Here’s what you need to know before you roll up your sleeve.
The COVID-19 vaccination programme requires stringent data collection and transparency.
Kontributor teratas
-
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
-
General Practitioner, PhD Candidate, Bond University
-
Associate Professor, Epidemiology, Deakin University
-
Deputy Director of the HUMLOG (Humanitarian Logistics and Supply Chain Management Research) Institute, Hanken School of Economics
-
Professor of Epidemiology Healthcare Infection and Infectious Diseases Control, UNSW Sydney
-
Adjunct Associate Professor, Menzies Centre for Health Policy, University of Sydney
-
Associate Professor, Discipline of Childhood and Adolescent Health, University of Sydney
-
Senior Associate, Grattan Institute
-
Director of the Digital Health Enterprise Zone (DHEZ), University of Bradford, Professor of Health Service Operations, University of Bradford
-
Chair in Epidemiology, Deakin University
-
Consultant Neonatologist and Professor of Ethics, University of Oxford
-
Research Fellow in Applied Moral Philosophy, University of Oxford
-
Research Fellow, Vaccine Uptake Group, Murdoch Children's Research Institute
-
Professor of Global Biosecurity, NHMRC L3 Research Fellow, Head, Biosecurity Program, Kirby Institute, UNSW Sydney
-
Paediatrician at the Royal Childrens Hospital and Associate Professor and Clinician Scientist, University of Melbourne and MCRI, Murdoch Children's Research Institute
